Global Autoimmune Monoclonal Antibodies Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2030

Report ID: IBI1622145 | Category: Pharma & Healthcare | Pages: 130 | Format: PDF | Published Date: August 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3550.00 Multi User-$4550.00

Report Description
View Table of Contents

Report Summary

Autoimmune diseases are the condition in which body own immune system mistakenly attack normal body. In autoimmune diseases production of autoantibodies occurs which attack the healthy cell of body. Autoimmune monoclonal antibodies are the agents which acts as immunotherapy agent and protect the body healthy cell from the damage.
According to our (Global Info Research) latest study, the global Autoimmune Monoclonal Antibodies market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Autoimmune Monoclonal Antibodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Autoimmune Monoclonal Antibodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Autoimmune Monoclonal Antibodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Autoimmune Monoclonal Antibodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Autoimmune Monoclonal Antibodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Autoimmune Monoclonal Antibodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Autoimmune Monoclonal Antibodies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Mylan N.V, Sanofi, Pfizer Inc and GSK plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Autoimmune Monoclonal Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    TNF Class
    Interleukins
    Integrins
    B-Cell Depletion and Inhibition Targets
    T Cell Depletion Targets
Market segment by Application
    Rheumatoid Arthritis
    Systemic Lupus Erythematosus
    Multiple Sclerosis
    Organ Transplant Rejection
    Others
Major players covered
    F. Hoffmann-La Roche Ltd
    Mylan N.V
    Sanofi
    Pfizer Inc
    GSK plc
    Novartis AG
    Bayer AG
    Lilly
    Merck & Co., Inc
    Sun Pharmaceutical Industries Ltd
    Aurobindo Pharma
    Lupin
    Fresenius Kabi AG
    Akorn Incorporated
    Teva Pharmaceutical Industries Ltd
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Autoimmune Monoclonal Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Autoimmune Monoclonal Antibodies, with price, sales, revenue and global market share of Autoimmune Monoclonal Antibodies from 2019 to 2023.
Chapter 3, the Autoimmune Monoclonal Antibodies competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Autoimmune Monoclonal Antibodies breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2019 to 2023.and Autoimmune Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2023 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Autoimmune Monoclonal Antibodies.
Chapter 14 and 15, to describe Autoimmune Monoclonal Antibodies sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Autoimmune Monoclonal Antibodies Introduction
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Autoimmune Monoclonal Antibodies Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 TNF Class
        1.3.3 Interleukins
        1.3.4 Integrins
        1.3.5 B-Cell Depletion and Inhibition Targets
        1.3.6 T Cell Depletion Targets
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Autoimmune Monoclonal Antibodies Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Rheumatoid Arthritis
        1.4.3 Systemic Lupus Erythematosus
        1.4.4 Multiple Sclerosis
        1.4.5 Organ Transplant Rejection
        1.4.6 Others
    1.5 Global Autoimmune Monoclonal Antibodies Market Size & Forecast
        1.5.1 Global Autoimmune Monoclonal Antibodies Consumption Value (2019 & 2022 & 2030)
        1.5.2 Global Autoimmune Monoclonal Antibodies Sales Quantity (2019-2030)
        1.5.3 Global Autoimmune Monoclonal Antibodies Average Price (2019-2030) 
2 Manufacturers Profiles
    2.1 F. Hoffmann-La Roche Ltd
        2.1.1 F. Hoffmann-La Roche Ltd Details
        2.1.2 F. Hoffmann-La Roche Ltd Major Business
        2.1.3 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product and Services
        2.1.4 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
    2.2 Mylan N.V
        2.2.1 Mylan N.V Details
        2.2.2 Mylan N.V Major Business
        2.2.3 Mylan N.V Autoimmune Monoclonal Antibodies Product and Services
        2.2.4 Mylan N.V Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.2.5 Mylan N.V Recent Developments/Updates
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Autoimmune Monoclonal Antibodies Product and Services
        2.3.4 Sanofi Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.3.5 Sanofi Recent Developments/Updates
    2.4 Pfizer Inc
        2.4.1 Pfizer Inc Details
        2.4.2 Pfizer Inc Major Business
        2.4.3 Pfizer Inc Autoimmune Monoclonal Antibodies Product and Services
        2.4.4 Pfizer Inc Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.4.5 Pfizer Inc Recent Developments/Updates
    2.5 GSK plc
        2.5.1 GSK plc Details
        2.5.2 GSK plc Major Business
        2.5.3 GSK plc Autoimmune Monoclonal Antibodies Product and Services
        2.5.4 GSK plc Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.5.5 GSK plc Recent Developments/Updates
    2.6 Novartis AG
        2.6.1 Novartis AG Details
        2.6.2 Novartis AG Major Business
        2.6.3 Novartis AG Autoimmune Monoclonal Antibodies Product and Services
        2.6.4 Novartis AG Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.6.5 Novartis AG Recent Developments/Updates
    2.7 Bayer AG
        2.7.1 Bayer AG Details
        2.7.2 Bayer AG Major Business
        2.7.3 Bayer AG Autoimmune Monoclonal Antibodies Product and Services
        2.7.4 Bayer AG Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.7.5 Bayer AG Recent Developments/Updates
    2.8 Lilly
        2.8.1 Lilly Details
        2.8.2 Lilly Major Business
        2.8.3 Lilly Autoimmune Monoclonal Antibodies Product and Services
        2.8.4 Lilly Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.8.5 Lilly Recent Developments/Updates
    2.9 Merck & Co., Inc
        2.9.1 Merck & Co., Inc Details
        2.9.2 Merck & Co., Inc Major Business
        2.9.3 Merck & Co., Inc Autoimmune Monoclonal Antibodies Product and Services
        2.9.4 Merck & Co., Inc Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.9.5 Merck & Co., Inc Recent Developments/Updates
    2.10 Sun Pharmaceutical Industries Ltd
        2.10.1 Sun Pharmaceutical Industries Ltd Details
        2.10.2 Sun Pharmaceutical Industries Ltd Major Business
        2.10.3 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
        2.10.4 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.10.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    2.11 Aurobindo Pharma
        2.11.1 Aurobindo Pharma Details
        2.11.2 Aurobindo Pharma Major Business
        2.11.3 Aurobindo Pharma Autoimmune Monoclonal Antibodies Product and Services
        2.11.4 Aurobindo Pharma Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.11.5 Aurobindo Pharma Recent Developments/Updates
    2.12 Lupin
        2.12.1 Lupin Details
        2.12.2 Lupin Major Business
        2.12.3 Lupin Autoimmune Monoclonal Antibodies Product and Services
        2.12.4 Lupin Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.12.5 Lupin Recent Developments/Updates
    2.13 Fresenius Kabi AG
        2.13.1 Fresenius Kabi AG Details
        2.13.2 Fresenius Kabi AG Major Business
        2.13.3 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product and Services
        2.13.4 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.13.5 Fresenius Kabi AG Recent Developments/Updates
    2.14 Akorn Incorporated
        2.14.1 Akorn Incorporated Details
        2.14.2 Akorn Incorporated Major Business
        2.14.3 Akorn Incorporated Autoimmune Monoclonal Antibodies Product and Services
        2.14.4 Akorn Incorporated Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.14.5 Akorn Incorporated Recent Developments/Updates
    2.15 Teva Pharmaceutical Industries Ltd
        2.15.1 Teva Pharmaceutical Industries Ltd Details
        2.15.2 Teva Pharmaceutical Industries Ltd Major Business
        2.15.3 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product and Services
        2.15.4 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.15.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
3 Competitive Environment: Autoimmune Monoclonal Antibodies by Manufacturer
    3.1 Global Autoimmune Monoclonal Antibodies Sales Quantity by Manufacturer (2019-2022)
    3.2 Global Autoimmune Monoclonal Antibodies Revenue by Manufacturer (2019-2022)
    3.3 Global Autoimmune Monoclonal Antibodies Average Price by Manufacturer (2019-2022)
    3.4 Market Share Analysis (2021)
        3.4.1 Producer Shipments of Autoimmune Monoclonal Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2021
        3.4.2 Top 3 Autoimmune Monoclonal Antibodies Manufacturer Market Share in 2021
        3.4.2 Top 6 Autoimmune Monoclonal Antibodies Manufacturer Market Share in 2021
    3.5 Autoimmune Monoclonal Antibodies Market: Overall Company Footprint Analysis
        3.5.1 Autoimmune Monoclonal Antibodies Market: Region Footprint
        3.5.2 Autoimmune Monoclonal Antibodies Market: Company Product Type Footprint
        3.5.3 Autoimmune Monoclonal Antibodies Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Autoimmune Monoclonal Antibodies Market Size by Region
        4.1.1 Global Autoimmune Monoclonal Antibodies Sales Quantity by Region (2019-2030)
        4.1.2 Global Autoimmune Monoclonal Antibodies Consumption Value by Region (2019-2030)
        4.1.3 Global Autoimmune Monoclonal Antibodies Average Price by Region (2019-2030)
    4.2 North America Autoimmune Monoclonal Antibodies Consumption Value (2019-2030)
    4.3 Europe Autoimmune Monoclonal Antibodies Consumption Value (2019-2030)
    4.4 Asia-Pacific Autoimmune Monoclonal Antibodies Consumption Value (2019-2030)
    4.5 South America Autoimmune Monoclonal Antibodies Consumption Value (2019-2030)
    4.6 Middle East and Africa Autoimmune Monoclonal Antibodies Consumption Value (2019-2030)
5 Market Segment by Type
    5.1 Global Autoimmune Monoclonal Antibodies Sales Quantity by Type (2019-2030)
    5.2 Global Autoimmune Monoclonal Antibodies Consumption Value by Type (2019-2030)
    5.3 Global Autoimmune Monoclonal Antibodies Average Price by Type (2019-2030)
6 Market Segment by Application
    6.1 Global Autoimmune Monoclonal Antibodies Sales Quantity by Application (2019-2030)
    6.2 Global Autoimmune Monoclonal Antibodies Consumption Value by Application (2019-2030)
    6.3 Global Autoimmune Monoclonal Antibodies Average Price by Application (2019-2030)
7 North America
    7.1 North America Autoimmune Monoclonal Antibodies Sales Quantity by Type (2019-2030)
    7.2 North America Autoimmune Monoclonal Antibodies Sales Quantity by Application (2019-2030)
    7.3 North America Autoimmune Monoclonal Antibodies Market Size by Country
        7.3.1 North America Autoimmune Monoclonal Antibodies Sales Quantity by Country (2019-2030)
        7.3.2 North America Autoimmune Monoclonal Antibodies Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
    8.1 Europe Autoimmune Monoclonal Antibodies Sales Quantity by Type (2019-2030)
    8.2 Europe Autoimmune Monoclonal Antibodies Sales Quantity by Application (2019-2030)
    8.3 Europe Autoimmune Monoclonal Antibodies Market Size by Country
        8.3.1 Europe Autoimmune Monoclonal Antibodies Sales Quantity by Country (2019-2030)
        8.3.2 Europe Autoimmune Monoclonal Antibodies Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
    9.1 Asia-Pacific Autoimmune Monoclonal Antibodies Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Autoimmune Monoclonal Antibodies Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Autoimmune Monoclonal Antibodies Market Size by Region
        9.3.1 Asia-Pacific Autoimmune Monoclonal Antibodies Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Autoimmune Monoclonal Antibodies Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
    10.1 South America Autoimmune Monoclonal Antibodies Sales Quantity by Type (2019-2030)
    10.2 South America Autoimmune Monoclonal Antibodies Sales Quantity by Application (2019-2030)
    10.3 South America Autoimmune Monoclonal Antibodies Market Size by Country
        10.3.1 South America Autoimmune Monoclonal Antibodies Sales Quantity by Country (2019-2030)
        10.3.2 South America Autoimmune Monoclonal Antibodies Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
    11.1 Middle East & Africa Autoimmune Monoclonal Antibodies Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Autoimmune Monoclonal Antibodies Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Autoimmune Monoclonal Antibodies Market Size by Country
        11.3.1 Middle East & Africa Autoimmune Monoclonal Antibodies Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Autoimmune Monoclonal Antibodies Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
    12.1 Autoimmune Monoclonal Antibodies Market Drivers
    12.2 Autoimmune Monoclonal Antibodies Market Restraints
    12.3 Autoimmune Monoclonal Antibodies Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Autoimmune Monoclonal Antibodies and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Autoimmune Monoclonal Antibodies
    13.3 Autoimmune Monoclonal Antibodies Production Process
    13.4 Autoimmune Monoclonal Antibodies Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Autoimmune Monoclonal Antibodies Typical Distributors
    14.3 Autoimmune Monoclonal Antibodies Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Autoimmune Monoclonal Antibodies Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2030

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?